Skip to main content

End Point of Chemotherapy for TB Spine?

  • Chapter
  • First Online:
Tuberculosis of the Spine
  • 345 Accesses

Abstract

Tuberculosis is a major health problem in developing countries, and India is considered endemic for the disease. The management of spinal tuberculosis has come to a full circle. It has evolved drastically from an era of conservative treatment due to lack of good surgical techniques to an era of aggressive surgery with anterior reconstructions and now back to conservative treatment with better availability of diagnostic methods and superior understanding of the microbiology of the bug and the pharmacology of drugs.

Spinal tuberculosis is essentially a medical disease. Successful outcome of spinal tuberculosis relies on accurate histopathological and microbiological diagnosis, appropriate chemotherapeutic regimens, and optimum monitoring.

Though the chemotherapeutic regimen for sensitive TB is largely accepted, no consensus has been reached on appropriate duration of anti-tubercular drugs, as there has been no accepted definition of “healed status” in spinal TB.

In most studies, the duration of chemotherapy varies from 6 months to 12 months.

The end point of treatment is based on combination of clinical, radiological, and laboratory parameters, but the lack of hard criteria to define healed spinal TB keep the controversy about the duration of AKT alive.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  1. Global Tuberculosis report 2017: World Health Organisation.

    Google Scholar 

  2. Rajasekaran S, Prasad Shetty A, Dheenadhayalan J, Shashidhar Reddy J, Naresh-Babu J, Kishen T. Morphological changes during growth in healed childhood spinal tuberculosis a 15-year prospective study of 61 children treated with ambulatory chemotherapy. J Pediatr Orthop. 2006;26(6):716–24.

    Article  CAS  Google Scholar 

  3. Teo H, Peh W. Skeletal tuberculosis in children. Pediatr Radiol. 2004;34(11):853–60.

    Article  Google Scholar 

  4. Peto HM, Pratt RH, Harrington TA, LoBue PA, Armstrong LR. Epidemiology of extrapulmonary tuberculosis in the United States, 1993–2006. Clin Infect Dis. 2009;49:1350–7.

    Article  Google Scholar 

  5. Naim-ur-Rahman. Atypical forms of spinal tuberculosis. J Bone Joint Surg Br. 1980;62-B:162–5.

    Article  CAS  Google Scholar 

  6. Talbot JC, Bismil Q, Saralaya D, Newton D, Frizzel RM, Shaw DL. Musculoskeletal tuberculosis in bradford – a 6-year review. Ann R Coll Surg Engl. 2007;89:405–9.

    Article  CAS  Google Scholar 

  7. Jain AK. Tuberculosis of the spine: a fresh look at an old disease. J Bone Joint Surg Br. 2010;92:905–13.

    Article  CAS  Google Scholar 

  8. Kiran N, Vaishya S, Kale S, Sharma B, Mahapatra A. Surgical results in patients with tuberculosis of the spine and severe lower-extremity motor deficits: a retrospective study of 48 patients. J Neurosurg Spine. 2007;6(4):320–6.

    Article  Google Scholar 

  9. Jain A, Dhammi I. Tuberculosis of the spine. Clin Orthop Relat Res. 2007;460:39–4.

    Article  Google Scholar 

  10. Tuli S. Tuberculosis of the skeletal system. New Delhi: Jaypee Brothers Medical Publishers; 2010. p. 4.

    Book  Google Scholar 

  11. Thelander U, Larsson S. Quantitation of C-reactive protein and Erythrocyte sedimentation rate after spinal surgery. Spine. 1992;17(4):400–4.

    Article  CAS  Google Scholar 

  12. Singh R, Magu NK, Rohilla RK. Clinicoradiologic profile of involvement and healing in tuberculosis of the spine. Ann Med Health Sci Res. 2016;6(5):311–27.

    Article  CAS  Google Scholar 

  13. Antonio RG, Silvana SE, Carme TO, et al. Imaging findings of Pott’s disease. Eur Spine J. 2013;22(Suppl 4):567–78.

    Google Scholar 

  14. Jain AK, Srivastava A, Saini NS, Dhammi IK, Sreenivasan R, Kumar S. Efficacy of extended dots category i chemotherapy in spinal tuberculosis based on MRI-based healed status. Indian J Orthop. 2012;46:633–9.

    Article  Google Scholar 

  15. Nene AM, Patil S, Kathare AP, Nagad P, Nene A, Kapadia F. Six vs twelve months of anti-tubercular therapy in patients with biopsy proven spinal tuberculosis. A single centre, open labelled, prospective randomized clinical trial - a pilot study. Spine (Phila Pa 1976). 2019;44(1):E1–E6.

    Google Scholar 

  16. Ohtori S, Suzuki M, Koshi T, Yamashita M, Yamauchi K, Inoue G, et al. 18F- fluorodeoxyglucose-PET for patients with suspected spondylitis showing modic change. Spine (Phila Pa 1976). 2010;35:E1599–603.

    Article  Google Scholar 

  17. INDEX-TB guidelines - guidelines on extra-pulmonary tuberculosis for India. 2016. http://tbcindia.nic.in/showfile.php?lid=3245. Accessed 4 Apr 2017.

  18. Alland D, Kalkut GE, Moss AR, McAdam RA, Hahn JA, Bosworth W. Transmission of tuberculosis in new york city. an analysis by DNA fingerprinting and conventional epidemiologic methods. N Engl J Med. 1994;330:1710–6.

    Article  CAS  Google Scholar 

  19. Small PM, Hopewell PC, Singh SP, Paz A, Parsonnet J, Ruston DC. The epidemiology of tuberculosis in San Francisco – a population-based study using conventional and molecular methods. N Engl J Med. 1994;330:1703–9.

    Article  CAS  Google Scholar 

  20. Sahadevan R, Narayanan S, Paramasivan CN, Prabhakar R, Narayanan PR. Restriction fragment length polymorphism typing of clinical isolates of mycobacterium tuberculosis from patients with pulmonary tuberculosis in madras, India, by use of direct-repeat probe. J Clin Microbiol. 1995;33:3037–9.

    Article  CAS  Google Scholar 

  21. Das S, Chan SL, Allen BW, Mitchison DA, Lowrie DB. Application of DNA fingerprinting with IS986 to sequential mycobacterial isolates obtained from pulmonary tuberculosis patients in Hong Kong before, during and after short-course chemotherapy. Tuber Lung Dis. 1993;74:47–51.

    Article  CAS  Google Scholar 

  22. Rivas-Garcia A, Sarria-Estrada S, Torrents-Odin C, Casas-Gomila L, Franquet E. Imaging findings of Pott’s disease. Eur Spine J. 2013;22(Suppl 4):567–78.

    Article  Google Scholar 

  23. Kim S-J, Kim I-J, Suh KT, Kim Y-K, Lee JS. Prediction of residual disease of spine infection using F-18 FDG pet/ct. Spine. 2009;34:2424–30.

    Article  Google Scholar 

  24. Vorster M, Sathekge MM, Bomanji J. Advances in imaging of tuberculosis: the role of 18F-FDG pet and pet/ct. Curr Opin Pulm Med. 2014;20:287–93.

    Article  Google Scholar 

  25. Grigolato D, Del Rizzo M, Cucca M, Zuffante M, Concia E, Ferdeghini M. 18F-FDG PET/CT in tuberculosis: a single hospital experience. J Nucl Med. 2016;57:1742.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Abhay Nene .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Nene, A., Shah, M. (2022). End Point of Chemotherapy for TB Spine?. In: Dhatt, S.S., Kumar, V. (eds) Tuberculosis of the Spine. Springer, Singapore. https://doi.org/10.1007/978-981-16-9495-0_28

Download citation

  • DOI: https://doi.org/10.1007/978-981-16-9495-0_28

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-16-9494-3

  • Online ISBN: 978-981-16-9495-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics